Cargando…
Innate and Adaptive Responses of Intratumoral Immunotherapy with Endosomal Toll-Like Receptor Agonists
Toll-like receptors (TLRs) are natural initial triggers of innate and adaptive immune responses. With the advent of cancer immunotherapy, nucleic acids engineered as ligands of endosomal TLRs have been investigated for the treatment of solid tumors. Despite promising results, their systemic administ...
Autores principales: | Andón, Fernando Torres, Leon, Sergio, Ummarino, Aldo, Redin, Esther, Allavena, Paola, Serrano, Diego, Anfray, Clément, Calvo, Alfonso |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313389/ https://www.ncbi.nlm.nih.gov/pubmed/35884895 http://dx.doi.org/10.3390/biomedicines10071590 |
Ejemplares similares
-
Current Strategies to Target Tumor-Associated-Macrophages to Improve Anti-Tumor Immune Responses
por: Anfray, Clément, et al.
Publicado: (2019) -
Intratumoral combination therapy with poly(I:C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity
por: Anfray, Clément, et al.
Publicado: (2021) -
Targeting Tumor-Associated Macrophages in Anti-Cancer Therapies: Convincing the Traitors to Do the Right Thing
por: Belgiovine, Cristina, et al.
Publicado: (2020) -
Cancer Cell-Intrinsic Alterations Associated with an Immunosuppressive Tumor Microenvironment and Resistance to Immunotherapy in Lung Cancer
por: Otegui, Nerea, et al.
Publicado: (2023) -
Arginine-Based Poly(I:C)-Loaded Nanocomplexes for the Polarization of Macrophages Toward M1-Antitumoral Effectors
por: Dacoba, Tamara G., et al.
Publicado: (2020)